Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02073747 · ClinicalTrials.gov registry record · NA
The Various Effects of Gaseous Albuterol on Serum Lactate
A NA study, sponsored by University Medical Center of Southern Nevada.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02073747: Completed NA study, sponsored by University Medical Center of Southern Nevada.
NCT02073747 is a NA study that has completed, run by University Medical Center of Southern Nevada. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02073747, a NA study, has completed, sponsored by University Medical Center of Southern Nevada.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Empirical data from physician observation indicates an increase in serum lactate in acute asthmatic patients being treated with inhaled albuterol therapy. It is not clear if this increased serum lactate is in response to a physiological response to the asthmatic process or from the albuterol treatment. This study is designed to determine if administration of inhaled albuterol increases serum lactate in healthy subjects.
Primary Outcome
We powered our study to detect a difference of 0.5 mmol/L between pre and post-treatment lactate levels, but hypothesize that the difference will be greater than 1.0 mmol/L.
Interventions
- DRUG Normal Saline
- DRUG Albuterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-04 |
| Est. Completion | 2015-08 |
| Phase | NA |
What the finished NCT02073747 record still lists
NCT02073747 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT02073747 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02073747 about?
NCT02073747 is a clinical study titled "The Various Effects of Gaseous Albuterol on Serum Lactate". Empirical data from physician observation indicates an increase in serum lactate in acute asthmatic patients being treated with inhaled albuterol therapy. It is not clear if this increased serum lactate is in response to a physiological response to the asthmatic process or from the albuterol treatm...
What is the current status of trial NCT02073747?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2015-04. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02073747?
The interventions under investigation include: Normal Saline (DRUG), Albuterol (DRUG).
Who is sponsoring clinical trial NCT02073747?
This trial is sponsored by University Medical Center of Southern Nevada, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02073747's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia